Literature DB >> 6419350

Does smoking increase medical care expenditure?

R E Leu, T Schaub.   

Abstract

The impact of smoking on medical care expenditure is analyzed, challenging the widespread belief that smoking imposes a large cost burden on health services systems. The results imply that lifetime expenditure is higher for nonsmokers than for smokers because smokers' higher annual utilization rates are overcompensated for by nonsmokers' higher life expectancy. Population simulation, taking into account the effects of past smoking on present population size and composition, suggests that 1976 expenditure would have been the same if no male born since 1876 had ever smoked. The male population would have been larger, particularly at older ages, increasing medical care expenditure, but this increase would have been offset by lower annual medical care utilization rates. Thus the results imply that smoking does not increase medical care expenditure and, therefore, reducing smoking is unlikely to decrease it.

Mesh:

Year:  1983        PMID: 6419350     DOI: 10.1016/0277-9536(83)90168-5

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  18 in total

Review 1.  Medical costs of smoking in the United States: estimates, their validity, and their implications.

Authors:  K E Warner; T A Hodgson; C E Carroll
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

Review 2.  The economics of tobacco: myths and realities.

Authors:  K E Warner
Journal:  Tob Control       Date:  2000-03       Impact factor: 7.552

3.  Optimal commodity taxation with moral hazard and unobservable outcomes.

Authors:  Gerard Russo
Journal:  Int J Health Care Finance Econ       Date:  2003-03

4.  Health care costs among smokers, former smokers, and never smokers in an HMO.

Authors:  Paul A Fishman; Zeba M Khan; Ella E Thompson; Susan J Curry
Journal:  Health Serv Res       Date:  2003-04       Impact factor: 3.402

Review 5.  The economics of smoking: an overview of the international and New Zealand literature.

Authors:  D Phillips; I Kawachi; M Tilyard
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

6.  Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation.

Authors:  Harold S Javitz; Susan M Zbikowski; Mona Deprey; Timothy A McAfee; Jennifer B McClure; Julie Richards; Sheryl L Catz; Lisa M Jack; Gary E Swan
Journal:  Transl Behav Med       Date:  2011-03-01       Impact factor: 3.046

Review 7.  Economic implications of smoking cessation therapies: a review of economic appraisals.

Authors:  D R Cohen; G H Fowler
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

8.  Evaluation of the economic impact of California's Tobacco Control Program: a dynamic model approach.

Authors:  Leonard S Miller; Wendy Max; Hai-Yen Sung; Dorothy Rice; Malcolm Zaretsky
Journal:  Tob Control       Date:  2010-04       Impact factor: 7.552

9.  Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.

Authors:  Betty Tao; Massimo Pietropaolo; Mark Atkinson; Desmond Schatz; David Taylor
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

10.  [Health and social sequelae of drug abuse].

Authors:  A Uchtenhagen
Journal:  Soz Praventivmed       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.